Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
18.83
-0.92 (-4.66%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Company Description
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong.
The company focuses on advancing human health and longevity through science-backed products under the IM8 brand.
It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories.
The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Prenetics Global Limited
| Country | Hong Kong |
| Founded | 2014 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 98 |
| CEO | Sheng Wu Yeung |
Contact Details
Address: Unit 703-706, K11 Atelier King’s Road, 728 King’s Road Quarry Bay Hong Kong | |
| Phone | 852 2210 9588 |
| Website | prenetics.com |
Stock Details
| Ticker Symbol | PRE |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001876431 |
| CUSIP Number | G72245106 |
| ISIN Number | KYG722451229 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Sheng Wu Yeung | Co-Founder, Chairperson and Chief Executive Officer |
| Brian J. Rosin | Chief Financial Officer |
| Dr. Senthil Kumar Sundaram M.D. | Chief Clinical Officer |
| David Eric Vanderveen | President of Americas |
| Dr. James DiNicolantonio | Chief Nutrition Officer, Member of Scientific and Medical Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 10, 2026 | 6-K | Report of foreign issuer |
| Jun 4, 2026 | 6-K | Report of foreign issuer |
| May 20, 2026 | 6-K | Report of foreign issuer |
| May 14, 2026 | 6-K | Report of foreign issuer |
| May 14, 2026 | 6-K | Report of foreign issuer |
| May 7, 2026 | 6-K | Report of foreign issuer |
| May 4, 2026 | 6-K | Report of foreign issuer |
| Apr 30, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Apr 22, 2026 | SCHEDULE 13G/A | Filing |
| Apr 2, 2026 | 6-K | Report of foreign issuer |